This Case CCC Cytometry &Imaging Microscopy Core provides access to instrumentation, instrumentation specific training, experimental consultation, data analysis, and data analysis training. By special request, the Core provides technical services preliminary to measurement such as cell culture, fixation, staining, etc. The Core covers flow cytometry, laser scanning cytometry, imaging flow cytometry, fluorescence-activated cell sorting (FACS), automated live-dead cell counting, confocal laser scanning microscopy, fluorescence video microscopy, and bright field automated whole slide imaging and has up-to-date analytical software for each activity. These services are broad-based, providing fundamental tools for basic sciences. The Core has two sites on the CWRU campus and another site through an alliance with the Case Center for AIDS Research (CFAR). The services are: 1) user access to instruments, 2) staff assisted use of instruments, and 3) performed by staff. The user base consists largely of Case CCC members from all the Research Programs with members from the Hematopoietic Disorders, Developmental Therapeutics, and Cancer Imaging Programs being the heaviest users. Overall, this Core provides fundamental services that may or may not be a large part of any one particular paper or grant but support the research efforts of a well-funded and highly published group of investigators. Services such as cell counting, cell sorting, or simple immunofluorescence analysis may or may not make it into a publication even though they are used on a daily basis to maintain cell lines, quality control cells, or to provide analysis that impacts the direction of research represented by publications and grants. The Core has been critical in studies that: provided a mechanism-based rationale for the development of HDAC and HAUSP inhibitors for combined use in cancer therapy;elucidated the mechanisms that initiate and maintain OIS in epithelial cells;and determining the inhibitory role for KLF4 during breast cancer metastasis.

Public Health Relevance

The Case Comprehensive Cancer Center is Northeast Ohio's only NCI designated comprehensive cancer center providing bench-to-bedside medical research involving partnerships between basic, clinical and population scientists to speed translation of laboratory discoveries into new prevention/intervention and cancer treatments.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Case Western Reserve University
United States
Zip Code
Levinson, Kimberly L; Jernigan, Amelia M; Flocke, Susan A et al. (2016) Intimate Partner Violence and Barriers to Cervical Cancer Screening: A Gynecologic Oncology Fellow Research Network Study. J Low Genit Tract Dis 20:47-51
Cooper, Gregory S; Kou, Tzuyung D; Schluchter, Mark D et al. (2016) Changes in Receipt of Cancer Screening in Medicare Beneficiaries Following the Affordable Care Act. J Natl Cancer Inst 108:
Wiechert, Andrew; Saygin, Caner; Thiagarajan, Praveena S et al. (2016) Cisplatin induces stemness in ovarian cancer. Oncotarget 7:30511-22
Somasegar, Sahana; Li, Li; Thompson, Cheryl L (2016) No association of reproductive risk factors with breast cancer tumor grade. Eur J Cancer Prev :
Kenyon, Jonathan; Nickel-Meester, Gabrielle; Qing, Yulan et al. (2016) Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell Clones is Defined by the Promoter CpG Methylation Pattern Observed by High-Throughput Methylation Specific Sequencing. Int J Stem Cell Res Ther 3:
Dowlati, A; Lipka, M B; McColl, K et al. (2016) Clinical correlation of extensive-stage small-cell lung cancer genomics. Ann Oncol 27:642-7
Markowitz, Sanford D; Nock, Nora L; Schmit, Stephanie L et al. (2016) A Germline Variant on Chromosome 4q31.1 Associates with Susceptibility to Developing Colon Cancer Metastasis. PLoS One 11:e0146435
Wang, Y; Deng, O; Feng, Z et al. (2016) RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression. Oncogene 35:1363-72
Doherty, Mary R; Smigiel, Jacob M; Junk, Damian J et al. (2016) Cancer Stem Cell Plasticity Drives Therapeutic Resistance. Cancers (Basel) 8:
Blum, Andrew E; Venkitachalam, Srividya; Guo, Yan et al. (2016) RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas. Cancer Res 76:5628-5633

Showing the most recent 10 out of 1148 publications